Medical and Biomedical Technology

Protein stabilization refers to the process of engineering proteins to be more stable or resistant to harsh conditions. This involves modifying protein structure or introducing mutations that enhance protein stability. Protein stabilization is important for various applications, such as developing therapeutic proteins with longer half-lives, creating enzymes that can withstand extreme temperatures or pH conditions, and designing biomaterials with improved durability.

Protein catalysis refers to the process of engineering proteins to have specific catalytic activities. This involves modifying protein structure or introducing mutations that enhance the protein's ability to catalyze specific chemical reactions. Protein catalysis is important for various applications, such as developing enzymes for industrial processes, creating biosensors for detecting specific molecules, and designing biomaterials with catalytic properties.

Protein engineering is used in the materials science industry to create biomaterials. Biomaterials are materials derived from biological sources or inspired by biological systems. Protein engineering techniques are used to create proteins with specific structural properties, mechanical strength, and biocompatibility. These engineered proteins can be used to develop biomaterials for various applications, such as tissue engineering, drug delivery, and biosensors.

Protein binding refers to the process of engineering proteins to have specific binding properties. This involves modifying protein structure or introducing mutations that enhance the protein's ability to bind to specific molecules or surfaces. Protein binding is important for various applications, such as developing therapeutic proteins that target specific receptors, creating biosensors for detecting specific molecules, and designing biomaterials with specific binding properties.

The Hodgkin-Huxley model is a system of differential equations that describes the electrical activity of the heart. It is used to simulate the heart's response to various conditions, such as changes in heart rate, blood pressure, and the effects of drugs.

The reaction-diffusion model is a mathematical model that describes the growth and spread of cancer cells. It is used to simulate the effects of different treatments on cancer cells and predict how the disease will progress.

Molecular therapeutics focuses on developing drugs that specifically target molecules or pathways involved in disease processes, aiming to modulate their activity and restore normal cellular function.

Molecular therapeutics utilizes various technologies for developing targeted therapies, including high-throughput screening to identify potential drug candidates, molecular docking to predict drug-target interactions, and computational biology to design and optimize drug molecules.

Immunotherapy aims to harness the power of the immune system to recognize and attack cancer cells. It involves enhancing the immune response or modifying immune cells to target and eliminate cancer cells.

Monoclonal antibodies are designed to target and neutralize specific antigens or molecules involved in disease processes. They can block the activity of these molecules, inhibit cell signaling pathways, or mark cells for destruction by the immune system.

Monoclonal antibody production involves a combination of hybridoma technology to generate hybrid cells that produce antibodies, recombinant DNA technology to clone and express antibody genes, and protein engineering to optimize antibody properties.

CO2 lasers are commonly used in laser surgery because they can produce a precise and focused beam of energy that can be used to vaporize or cut tissue.

Ultrasound surgery works by generating high-frequency sound waves, which cause tissue to vibrate and be destroyed.

Cryosurgery works by freezing tissue, causing it to be destroyed.

Electrosurgery is commonly used to perform laparoscopic surgery because it can provide precise control over the depth and extent of tissue destruction.